ULS vs. NEO, APDN, EFX, RKT, APP, GPN, VLTO, SYM, BR, and KSPI
Should you be buying UL Solutions stock or one of its competitors? The main competitors of UL Solutions include NeoGenomics (NEO), Applied DNA Sciences (APDN), Equifax (EFX), Rocket Companies (RKT), AppLovin (APP), Global Payments (GPN), Veralto (VLTO), Symbotic (SYM), Broadridge Financial Solutions (BR), and Joint Stock Company Kaspi.kz (KSPI).
UL Solutions (NYSE:ULS) and NeoGenomics (NASDAQ:NEO) are both business services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, valuation, media sentiment, profitability, analyst recommendations, community ranking and risk.
NeoGenomics received 483 more outperform votes than UL Solutions when rated by MarketBeat users. However, 86.67% of users gave UL Solutions an outperform vote while only 70.66% of users gave NeoGenomics an outperform vote.
UL Solutions presently has a consensus price target of $40.80, indicating a potential upside of 2.20%. NeoGenomics has a consensus price target of $19.78, indicating a potential upside of 39.97%. Given NeoGenomics' higher probable upside, analysts clearly believe NeoGenomics is more favorable than UL Solutions.
UL Solutions has higher earnings, but lower revenue than NeoGenomics.
In the previous week, UL Solutions had 17 more articles in the media than NeoGenomics. MarketBeat recorded 21 mentions for UL Solutions and 4 mentions for NeoGenomics. NeoGenomics' average media sentiment score of 1.28 beat UL Solutions' score of 0.79 indicating that NeoGenomics is being referred to more favorably in the news media.
98.5% of NeoGenomics shares are owned by institutional investors. 1.3% of NeoGenomics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
UL Solutions has a net margin of 0.00% compared to NeoGenomics' net margin of -13.79%. UL Solutions' return on equity of 0.00% beat NeoGenomics' return on equity.
Summary
UL Solutions beats NeoGenomics on 7 of the 13 factors compared between the two stocks.
Get UL Solutions News Delivered to You Automatically
Sign up to receive the latest news and ratings for ULS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ULS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
UL Solutions Competitors List
Related Companies and Tools
